| Combi-Chem |


Drug discovery projects have traditionally required testing hundreds or perhaps thousands of individually synthesized and characterized chemicals; the new techniques of robotic synthesis, combinatorial chemistry, and high-throughput screening (HTS) offer the possibility of rapidly preparing and testing hundreds of thousands or more samples. This increased throughput dramatically increases the probability of finding a lead compound with the proper balance of activity, specificity, safety, bioavailability, and stability to result in a successful new drug. The process involves the tight integration of synthesis and screening methods and can be subdivided into four interconnected activities: (1) library specification, (2) library design and analysis, (3) library data management, and (4) library structure activity relationship (SAR) determination. In many ways, this new process represents a microcosm of discovery efforts within pharmaceutical and agrochemical companies, where powerful analysis capabilities must be closely integrated with flexible project data management and laboratory automation.
Medicinal chemists working in drug discovery face questions such as:

In addition, a table of contents and index are included to help you find specific information.
You should already be familiar with some aspects of: